Skip to main content
. Author manuscript; available in PMC: 2007 Mar 2.
Published in final edited form as: Biochem Pharmacol. 2006 Oct 13;73(3):331–340. doi: 10.1016/j.bcp.2006.10.005

Figure 3.

Figure 3

Structures of the five most potent inhibitors. NSC 619196, N4-(12-((5-amino-6-chloro-4-pyrimidinyl)amino)dodecyl)-6-chloro-4,5-pyrimidinediamine; NSC 619195,N4-(12-((2-amino-6-chloro-4-pyrimidinyl)amino)dodecyl)-6-chloro-2,4-pyrimidinediamine; NSC 629621, N4-(10-((2-amino-6-chloro-4-pyrimidinyl)amino)decyl)-6-chloro-2,4-pyrimidinediamine; NSC 668602, 1-(12-(3-formyl-1H-indol-1-yl)dodecyl)-1H-indole-3-carbaldehyde; and NSC 618296,2-((9-((7-oxo-1,3,5-cycloheptatrien-1-yl)amino)nonyl)amino)-2,4,6-cycloheptatrien-1-one.